Literature DB >> 4457307

[Elimination kinetics and dosage of digoxin in patients in renal failure (author's transl)].

E E Ohnhaus, P Spring, L Dettli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4457307     DOI: 10.1055/s-0028-1108049

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  11 in total

1.  Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses.

Authors:  J R Koup; D J Greenblatt; W J Jusko; T W Smith; J Koch-Weser
Journal:  J Pharmacokinet Biopharm       Date:  1975-06

Review 2.  Is antiarrhythmic treatment in the elderly different? a review of the specific changes.

Authors:  Vera H M Deneer; Norbert M van Hemel
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

Review 3.  Clinical pharmacokinetics of cardiac glycosides in patients with renal dysfunction.

Authors:  J K Aronson
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

Review 4.  Disease-related alterations in cardiac glycoside disposition.

Authors:  H R Ochs; D J Greenblatt; G Bodem; H J Dengler
Journal:  Clin Pharmacokinet       Date:  1982 Sep-Oct       Impact factor: 6.447

5.  [The pharmacokinetics of digoxin during chronic spironolacton treatment (author's transl)].

Authors:  J P Masson; O Bass; H R Baur; E E Ohnhaus
Journal:  Klin Wochenschr       Date:  1978-11-01

Review 6.  Digitalis pharmacokinetics and therapy with respect to impaired renal function.

Authors:  P Kramer
Journal:  Klin Wochenschr       Date:  1977-01-01

Review 7.  Clinical pharmacokinetics of digoxin.

Authors:  E Iisalo
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

8.  Absorption of digoxin in severe right heart failure.

Authors:  E E Ohnhaus; S Vozeh; E Nuesch
Journal:  Eur J Clin Pharmacol       Date:  1979-03-26       Impact factor: 2.953

9.  Digoxin dosage in renal insufficiency: impracticality of basing it on the creatinine clearance, body weight and volume of distribution.

Authors:  F Keller; M Molzahn; R Ingerowski
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

10.  Relationship between dose and plasma level of digoxin and patient characteristics.

Authors:  N Heinz; N Rietbrock
Journal:  Eur J Clin Pharmacol       Date:  1979-03-26       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.